FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to methods for suppression of tumor cell proliferation. A method for suppression of tumor cell proliferation includes contact of tumor cells with cells of human placental perfusate, where a set of placental perfusate cells is a combination of nucleus-containing cells of placental perfusate. The method for suppression of tumor cell proliferation includes contact of tumor cells with combined natural killer cells, where the specified combined natural killer cells include natural killer cells isolated from placental perfusate and natural killer cells isolated from cord blood, where cord blood is isolated from placenta, from which the specified placental perfusate is obtained.
EFFECT: above-described methods allow for effective suppression of tumor cell growth.
40 cl, 14 dwg, 13 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TUMOUR SUPPRESSION WITH USE OF HUMAN PLACENTAL PERFUSATE AND AUXILIARY NATURAL KILLER CELLS RECOVERED FROM HUMAN PLACENTA | 2008 |
|
RU2536242C2 |
| SUPPRESSION OF TUMORS USING HUMAN PLACENTA DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATING COMPOUNDS | 2010 |
|
RU2742171C2 |
| TUMOUR SUPPRESSION WITH APPLICATION OF INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATORY COMPOUNDS OBTAINED FROM HUMAN PLACENTA | 2010 |
|
RU2642988C2 |
| IMPROVED CELL COMPOSITION AND METHODS OF OBTAINING THEREOF | 2009 |
|
RU2563518C2 |
| IMPROVED CELL COMPOSITION AND METHODS FOR ITS PREPARATION | 2009 |
|
RU2662676C1 |
| TREATMENT OF DISEASE, DISORDERS OR PATHOLOGICAL CONDITIONS OF LUNGS WITH APPLICATION OF PLACENTAL CELLS | 2009 |
|
RU2570550C2 |
| TREATING DISEASES, DISORDERS OR PATHOLOGICAL CONDITIONS OF THE LUNGS USING PLACENTAL CELLS | 2009 |
|
RU2732240C2 |
| STROKE TREATMENT WITH APPLICATION OF ISOLATED PLACENTAL CELLS | 2009 |
|
RU2558778C2 |
| METHOD FOR EXPANSION OF HUMAN NK CELLS USING FEEDER CELLS | 2021 |
|
RU2781777C2 |
| METHOD OF PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH UNRESECTABLE TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2802141C1 |
